Biologics

NervGen Pharma will use its developing drug technology for spinal cord injuries in a new multiple sclerosis program.

Biologics therapies have the promise to revolutionize orthopedics and sports medicine, but unauthorized operators pose a serious threat to emerging therapies.

Orthobiologics company Cerapedics appointed Patrick O'Connor to serve as vice president of clinical and market development.

Chinese biologics technology company WuXi Biologics is expanding its conjugation solution center to include commercial manufacturing later this year.

AlloSource partnered with Manufacturing USA in a new public-private initiative, the Advanced Regenerative Manufacturing Institute.

Granite Creek Capital Partners, a private investment firm in Chicago, invested in regenerative medicine company Royal Biologics.

Orthopedic and sports medicine technology company Ortho Regenerative Technologies unveiled Claude LeDuc as its new president and CEO, according to Biospace.

Regenerative Medicine Minnesota is a bipartisan effort to improve research, technology, education and patient access to regenerative medicine-based treatments.

Regenerative medicine has life-changing potential, but illegal actors are spurring a rash of regulatory activities.

Here are four key updates in about spinal biologics companies and advancements.